Acta Haematologica

eISSN: 1421-9662pISSN: 0001-5792

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
3.7
H-Index
60
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.92

Journal Specifications

Overview
  • Publisher
    KARGER
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Topics Covered

Gene expression
Diffuse large B-cell lymphoma
Hematopoietic stem cell transplantation
Thrombotic thrombocytopenic purpura
Aplastic anemia
Anemia
Immune thrombocytopenia
Imatinib
Overall survival
Myeloid sarcoma
Immunization
Bortezomib
Factor V
Surveillance, Epidemiology, and End Results
Genetic profile
Progression-free survival
Disease progression
Essential thrombocythemia
Rituximab
Iron deficiency

Recently Published Papers

Year-wise Publication

FAQs

Since when has Acta Haematologica been publishing? Faqs

The Acta Haematologica has been publishing since 1948 till date.

How frequently is the Acta Haematologica published? Faqs

Acta Haematologica is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Acta Haematologica? Faqs

Acta Haematologica has a H-index score of 60, Citescore of 3.7, SNIP score of 0.92, & SJR of Q2

Who is the publisher of Acta Haematologica? Faqs

The publisher of Acta Haematologica is KARGER.

How can I view the journal metrics of Acta Haematologica on editage? Faqs

For the Acta Haematologica metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Acta Haematologica? Faqs

The eISSN number is 1421-9662 and pISSN number is 0001-5792 for Acta Haematologica.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Gene expression, Diffuse large B-cell lymphoma, Hematopoietic stem cell transplantation, Thrombotic thrombocytopenic purpura, Aplastic anemia, Anemia, Immune thrombocytopenia, Imatinib, Overall survival, Myeloid sarcoma, Immunization, Bortezomib, Factor V, Surveillance, Epidemiology, and End Results, Genetic profile, Progression-free survival, Disease progression, Essential thrombocythemia, Rituximab, Iron deficiency.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.